Advertisement

Topics

Assay Designs Company Profile

08:54 EST 12th December 2018 | BioPortfolio

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Our rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit.
In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.

Location

5777 Hines Drive
Ann Arbor
Michigan
48108
United States of America

Contact

Phone: 734-668-6113
Fax: 734.668.2793
Email: orders@assaydesigns.com


News Articles [315 Associated News Articles listed on BioPortfolio]

New Troponin Assay May Facilitate Faster Rule-Out of AMI

In a preliminary study, a novel troponin assay with a 15-minute turnaround time shows similar accuracy and clinical sensitivity to a high-sensitivity assay. Medscape Medical News

Sensitive new assay finds abnormalities in tumour cells that other techniques may miss

RNA-Seq is a new next-generation assay that can detect gene fusions in solid tumour cells with high accuracy and excellent reproducibility. According to a new report in The Journal of Molecular Diagn...

Adaptive Biotechnologies gets FDA approval for clonoSEQ assay

The clonoSEQ assay, which uses DNA from a patient’s bone marrow sample, deploys next-generation sequencing (NGS) technology to evaluate disease burden. The clonoSEQ is the first and only The post A...

Dementia Assay Gets Favorable Evaluation

An assay to detect the most common genetic mutation associated with amyotropic lateral sclerosis (ALS) and frontotemporal dementia (FTD) has...

FDA approves cytomegalovirus assay for neonates

Meridian Bioscience has gained FDA approval for its Alethia CMV Assay Test System for the detection of cytomegalovirus in new -More- 

LabCorp's multiplex PCR assay for HCV, HIV, HBV gains FDA approval

The FDA has approved Laboratory Corporation of America's UltraQual Multiplex polymerase chain reaction assay as a screening d -More- 

NGS Assay for MRD Detection Gains FDA Approval for 2 Blood Cancers

The FDA has approved the next-generation sequencing assay clonoSEQ as a test for minimal residual disease (MRD) in patients with acute lymphoblastic leukemia or multiple myeloma.

FDA OKs New Molecular Assay for Blood Compatibility Testing

The ID CORE XT is the second molecular assay approved by FDA for use in transfusion medicine and the first to report genotypes as final results. FDA Approvals

PubMed Articles [986 Associated PubMed Articles listed on BioPortfolio]

A Systematic Comparison of Designs to Study Human Fecundity.

Several epidemiologic designs allow studying fecundability, the monthly probability of pregnancy occurrence in non-contracepting couples in the general population. These designs may, to varying extent...

Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.

Crossover designs robust to changes in carryover models are useful in clinical trials where the nature of carryover effects is not known in advance. The designs have been characterized for being optim...

Designing phase II clinical trials to target subgroup of interest in a heterogeneous population: A case study using an R package.

Phase II trials that evaluate target therapies based on a biomarker must be well designed in order to assess anti-tumor activity as well as clinical utility of the biomarker. Classical phase II design...

Current Knee Arthroplasty Designs and Kinematics: Differences in Radii, Conformity and Pivoting.

Today, there is an almost endless variety of knee prosthesis models on the market from which the surgeon can choose. Although the designs appear closer and closer to one another, the industry makes a ...

Corvid Technologies: How Do New Caledonian Crows Get Their Tool Designs?

Recent research shows that New Caledonian crows can incorporate information from researcher-made objects into objects they subsequently manufacture. This 'mental template matching' is one of several p...

Clinical Trials [829 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance Evaluation of DxN CMV Assay

The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study ...

Clinical Performance Evaluation of AMH Assay

The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay i...

Test Semiquantitative Prostate Specific Antigen (PSA)

The aim of the study is to compare the diagnostic performances of a simple and rapid PSA assay on whole blood to the standard plasma PSA assay.

PoC-HCV Genedrive Viral Detection Assay Validation Study

The principal objective is to assess the diagnostic accuracy of the PoC assay (Genedrive, Epistem) to detect HCV RNA against the reference standard of commercial real-time polymerase chain...

Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation

We will investigate potential correlation between SpermComet DNA fragmentation assay results and IVF cycle outcome.

Companies [751 Associated Companies listed on BioPortfolio]

Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets ...

Assay Designs Inc.

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Our rap...

Assay Designs

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Our rap...

Assay Designs Incorporated

Assay Designs, Inc. was formed in 1992 to bring the highest quality products to the research community. We have been involved in the development of chemiluminescent and bioluminescent systems and thei...

Clinical Ligand Assay Society's

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and f...

More Information about "Assay Designs" on BioPortfolio

We have published hundreds of Assay Designs news stories on BioPortfolio along with dozens of Assay Designs Clinical Trials and PubMed Articles about Assay Designs for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Assay Designs Companies in our database. You can also find out about relevant Assay Designs Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record